- Published at
- by manilatimes.net
positive
positive
News for Medigene AG (MDGEF)
- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
positivepositive- Published at
- by investing.com
mixedmixedCureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update By Investing.com
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update- Published at
- by manilatimes.net
positivepositive- Published at
- by globenewswire.com
neutralneutralMedigene to Present at Upcoming Investor Conferences
Planegg/Martinsried, October 29, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...- Published at
- by seekingalpha.com
neutralneutralMedigene AG reports Q3 results (MDGEF:Pink Current Info)
Medigene AG reports Q3 2024 revenues of €1.4M, reiterates guidance for 2024, and holds €9.5M in cash and equivalents.- Published at
- by globenewswire.com
positivepositiveMedigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024
Planegg/Martinsried, October 17, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...- Published at
- by globenewswire.com
positivepositiveMedigene to Present at Upcoming Scientific Conferences
Planegg/Martinsried, October 16, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...- Published at
- by globenewswire.com
neutralneutralMedigene will Present at ASGCT 2024 and Host R&D Event
Planegg/Martinsried, October 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...- Published at
- by globenewswire.com
positivepositiveMedigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021
Planegg/Martinsried, September 25, 2024 – Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...- Published at
- by marketscreener.com
mixedmixedScibase : Presentation Board of directors AGM 2024
Presentation of the proposed board members to the Annual General Meeting on 13 May 2024 Jesper Høiland - born 1960, chairman Education:...- Published at
- by globenewswire.com
mixedmixedGlobal Botanical Drugs Market Size is Estimated to Reach USD 3,431.32 million in 2031, Growing at a CAGR of 39%: Straits Research
Europe's booming botanical drug market is expected to reach a whopping USD 1.1 billion by 2031, driven by high cancer rates and a surge in research on...- Published at
- by globenewswire.com
mixedmixedNeoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research
The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...- Published at
- by markets.businessinsider.com
negativenegativeGlobal Neoantigen Cancer Vaccine (Synthetic Long Peptide, Nucleic Acid, Dendritic Cell, Tumor Cell) Market Report 2021
DUBLIN, July 30, 2021 /PRNewswire/ -- The 'Global Neoantigen Cancer Vaccine Market, By Product, By Neoantigen Type, By Route of Administration, By...- Published at
- by seekingalpha.com
negativenegativeMedigene pulls plug on MDG1021 development program (OTCMKTS:MDGEF)
Clinical stage immuno-oncology company Medigene AG (OTCPK:MDGEF) announces the discontinuation of its blood cancer treatment MDG1021's development program, as it looks to focus on the...